Naropin Injection, Solution
Product Images NDC 63323-288

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Naropin (NDC 63323-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nov0h 0001 01

Chemical structure of ropivacaine hydrochloride monohydrate, showing the chemical formula C17H26N2O·HCl·H2O and a molecular weight of 328.89.*

FDA Label Image

Nov0h 0001 02

FDA Label Image

Nov0h 0001 03

Naropin 0.2% (ropivacaine HCl injection, USP) 200 mg per 100 mL (2 mg per mL) injection solution in a 100 mL container. The label states it is for infiltration, nerve block, and epidural administration only, not for intravenous use. It is a single-dose product with no preservatives, manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Nov0h 0001 04

Label for Naropin (ropivacaine HCl Injection, USP) 0.5% solution, providing 150 mg per 30 mL (5 mg per mL) in a 30 mL single-dose vial. Intended for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Nov0h 0001 05

Label for Naropin (ropivacaine HCl injection, USP) 0.5% solution, 5 mg per mL strength. The product is provided in twenty-five 30 mL single dose vials. Indicated for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Nov0h 0001 06

Naropin 10 mg/mL (ropivacaine HCl injection, USP) epidural solution in a 20 mL single dose vial. The label indicates a strength of 1% (200 mg per 20 mL) and states use for epidural administration only, not intravenous. Manufactured by Fresenius Kabi USA, LLC, with storage instructions at controlled room temperature (20° to 25°C). The brand Novaplus is also referenced.*

FDA Label Image

Nov0h 0001 07

Naropin (ropivacaine HCl injection, USP) 1% injection solution in a 20 mL single dose vial. The label indicates 200 mg per 20 mL (10 mg per mL) strength for epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC, the label includes formulation details and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.